Join us for a 90 min discussion to meet the experts and ask questions regarding their talks.
Each panelist will provide a brief update since their presentations:
- Megan Troxell – Update on ER and PR Testing in Breast Cancer
- Andrew Bellizzi – High-Grade Neoplasms of Uncertain Lineage: Do’s and Don’ts of “Ancillary” Testing
- Paul Swanson – The Future of Immunohistochemistry
At the end of the session, participants will be able to:
- Recognize the role of ER as both a prognostic and predictive marker
- Appreciate the evolving role of image-based analysis of diagnostic histopathologic material
- Recognize the strengths and weaknesses of RNA sequencing and gene expression profiling testing for tumor diagnosis
Expert Panelists:
- Megan Troxell, MD, PhD, Professor of Pathology, Stanford University
- Andrew Bellizzi, Clinical Professor, Department of Pathology, University of Iowa
- Paul E. Swanson, MD, Professor of Pathology, Department of Pathology, University of Washington School of Medicine, Seattle WA
Host: Heather Dow, CAP-ACP Executive Director
Target audience: Pathologists, Residents, Lab Technicians
CanMEDS Roles: Medical Expert, Communicator